The novel therapy of this peptide represents a exciting development in the handling of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide722760.look4blog.com/79843506/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment